US SB3478 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to provide for the designation of biological products as qualified infectious disease products.
Title
GAIN TOOLS Act of 2022 Generating Antibiotic Incentives Now Through Opening Opportunities to Leverage Science Act of 2022
Sponsors
| Sen. Robert Casey [D-PA] | Sen. Bill Cassidy [R-LA] | Sen. Christopher Murphy [D-CT] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-01-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/3478/all-info |
| Text | https://www.congress.gov/117/bills/s3478/BILLS-117s3478is.pdf |
